Citalopram Hydrobromide
12 NDCs across 4 manufacturers|12 Generic,0 Brand
Citalopram Hydrobromide is used to treat alcoholism, dementia, depressive disorder, diabetic neuropathies, obsessive-compulsive disorder and tobacco use disorder, per the National Library of Medicine's MED-RT classification.
▸ More about this market▾ Less
The brand product was first FDA-approved on Jul 17, 1998, and the first generic was approved Oct 28, 2004. FDA's Orange Book lists 26 AB-rated (therapeutically equivalent) products for this ingredient. In 2024, Medicare Part D spent $51 million on Citalopram Hydrobromide across 6.7 million claims for 1.4 million beneficiaries.
Citalopram Hydrobromide is available as 12 NDCs from 4 manufacturers (12 generic, 0 brand), with NADAC prices from $0.02 to $0.04 per EA — a 70% difference between cheapest and most expensive. Every pack size and labeler in this drug market is compared side-by-side below.
Total NDCs
12
12G / 0B
Manufacturers
4
competing in market
Price Spread
$0.02 – $0.04
per EA, 10 of 12 NDCs
7d Activity
avg +0.9% WoW · of 12 NDCs
Market Price Trend
Monthly average NADAC per unit, split by generic and brand.
Manufacturer Breakdown
4 manufacturers producing CITALOPRAM HYDROBROMIDE
| Drug ↕ | Price | 7d Change ↕ |
|---|---|---|
CITALOPRAM HBR 10 MG/5 ML SOLN | $0.2248 per ML | — |
CITALOPRAM HBR 10 MG/5 ML SOLN | $0.1700 per ML | +0.69% |
CITALOPRAM HBR 40 MG TABLET | $0.0420 per EA | -0.26% |
CITALOPRAM HBR 40 MG TABLET | $0.0420 per EA | -0.26% |
CITALOPRAM HBR 40 MG TABLET | $0.0420 per EA | -0.26% |
CITALOPRAM HBR 40 MG TABLET | $0.0420 per EA | -0.26% |
CITALOPRAM HBR 20 MG TABLET | $0.0290 per EA | +1.97% |
CITALOPRAM HBR 20 MG TABLET | $0.0290 per EA | +1.97% |
CITALOPRAM HBR 20 MG TABLET | $0.0290 per EA | +1.97% |
CITALOPRAM HBR 10 MG TABLET | $0.0246 per EA | +1.57% |
CITALOPRAM HBR 10 MG TABLET | $0.0246 per EA | +1.57% |
CITALOPRAM HBR 10 MG TABLET | $0.0246 per EA | +1.57% |
Frequently Asked Questions
What is Citalopram Hydrobromide used to treat?
Citalopram Hydrobromide is used to treat alcoholism, dementia, depressive disorder, diabetic neuropathies, obsessive-compulsive disorder and tobacco use disorder, per the National Library of Medicine's MED-RT classification.
When did Citalopram Hydrobromide become available as a generic?
FDA approved the first generic Citalopram Hydrobromide (ANDA) on Oct 28, 2004. The Orange Book currently lists 26 AB-rated products for this ingredient, meaning FDA considers them therapeutically equivalent to the brand.
How much does Medicare spend on Citalopram Hydrobromide?
In 2024, Medicare Part D spent $51 million on Citalopram Hydrobromide across 6.7 million claims for 1.4 million beneficiaries.
How many Citalopram Hydrobromide products are on the market?
The Citalopram Hydrobromide drug market contains 12 NDCs from 4 manufacturers — 12 generic and 0 brand products.
What is the price range for Citalopram Hydrobromide?
NADAC reference prices for Citalopram Hydrobromide range from $0.0246 to $0.0420 per EA — a 70% difference between cheapest and most expensive. 2 additional products are priced per different units (e.g. liquids per ML) and aren't directly comparable.
Which manufacturers make Citalopram Hydrobromide?
4 manufacturers list Citalopram Hydrobromide in NADAC. Ranked by number of NDCs, the largest are Aurobindo Pharma Limited (7), Quallent Pharmaceuticals Health LLC (3), Camber Pharmaceuticals Inc. (1), Legacy Pharmaceutical Packaging, LLC (1).
How has the price of Citalopram Hydrobromide changed recently?
Over the past 7 days, 7 Citalopram Hydrobromide NDCs rose and 4 fell, with a market-wide average change of +0.9%.